Adam L. Braverman participated on a panel at the Pharmaceutical and Medical Device Ethics and Compliance Congress on Monday, October 24, 2022, in Washington, D.C. Adam was a panelist at the session entitled, "Recent Federal and State Enforcement Activities for the Pharma and Medical Device Industries".
The 23rd Annual Pharmaceutical and Medical Device Ethics and Compliance Program featured annual reports and updates provided by DOJ, FDA, and OIG, as well as discussions on more than 30 current topics addressing crucial ethics, compliance, and legal issues.